ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Heart Rhythm

Volumn 5, Issue 6, 2008, Pages 934-955

  Epstein, Andrew E ^a   DiMarco, John P ^a   Ellenbogen, Kenneth A ^a   Estes III, N A Mark ^a   Freedman, Roger A ^a   Gettes, Leonard S ^a   Gillinov, A Marc ^a   Gregoratos, Gabriel ^a   Hammill, Stephen C ^a   Hayes, David L ^a   Hlatky, Mark A ^a   Newby, L Kristin ^a   Page, Richard L ^a,a   Schoenfeld, Mark H ^a   Silka, Michael J ^a   Stevenson, Lynne Warner ^a   Sweeney, Michael O ^a   Smith Jr , Sidney C ^a   Jacobs, Alice K ^a   Adams, Cynthia D ^a   Anderson, Jeffrey L ^a   Buller, Christopher E ^a   Creager, Mark A ^a   Ettinger, Steven M ^a   Faxon, David P ^a   Halperin, Jonathan L ^a   Hiratzka, Loren F ^a   Hunt, Sharon A ^a   Krumholz, Harlan M ^a   Kushner, Frederick G ^a   Lytle, Bruce W ^a   Nishimura, Rick A ^a   Ornato, Joseph P ^a   Riegel, Barbara ^a   Tarkington, Lynn G ^a   Yancy, Clyde W ^a   more..

^a NONE

Author keywords

ACC AHA practice guideline; arrhythmia; cardiomyopathy; device based therapy; implantable cardioverter defibrillator; implantable coronary device; pacemaker; pacing

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; DIURETIC AGENT; FIBRINOLYTIC AGENT; INOTROPIC AGENT; PLACEBO; SOTALOL; THEOPHYLLINE;

ACUTE HEART INFARCTION; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR EQUIPMENT; CAROTID SINUS SYNDROME; CATHETER ABLATION; CLINICAL TRIAL; CONGENITAL HEART DISEASE; DEFIBRILLATOR; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE PACING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTATION; LONG QT SYNDROME; MEDICAL SOCIETY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLISHING; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SINUS NODE DYSFUNCTION; SUPRAVENTRICULAR TACHYCARDIA; SYNCOPE; SYSTOLIC HEART FAILURE; THERAPY EFFECT; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BRUGADA SYNDROME; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATION; DRUG DOSE TITRATION; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; FOLLOW UP; HEALTH CARE COST; HEART ATRIUM ARRHYTHMIA; HEART MUSCLE REVASCULARIZATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERMETHOD COMPARISON; MORTALITY; NEUROMUSCULAR DISEASE; POSITIVE END EXPIRATORY PRESSURE; PROCESS OPTIMIZATION; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; SHORT QT SYNDROME; SLEEP APNEA SYNDROME; STROKE; SUDDEN DEATH; TELECONSULTATION; TERMINAL CARE; THROMBOEMBOLISM; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT RESPONSE;

AMERICAN HEART ASSOCIATION; ARRHYTHMIAS, CARDIAC; ATRIOVENTRICULAR BLOCK; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; SINOATRIAL NODE; SOCIETIES, MEDICAL; THORACIC SURGERY; UNITED STATES; CARDIAC SURGICAL PROCEDURES; HEART FAILURE; MYOCARDIAL INFARCTION; PACEMAKER, ARTIFICIAL;

EID: 46349104535     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.04.015     Document Type: Review

References (160)

1. ACC/AHA Task Force on Practice Guidelines. Manual for ACC/AHA Guideline Writing Committees: Methodologies and Policies from the ACC/AHA Task Force on Practice Guidelines. Available at http://www.acc.org/qualityandscience/clinical/manual/pdfs/methodology.pd f and http://circ.ahajournals.org/manual/. Accessed February 2008.
2. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 40 (2002) 1703-1719
3. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106 (2002) 2145-2161
4. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006) e247-e346
5. Zwanziger J., Hall W.J., Dick A.W., et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 47 (2006) 2310-2318
6. Mushlin A.I., Hall W.J., Zwanziger J., et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation 97 (1998) 2129-2135
7. Mark D.B., Nelson C.L., Anstrom K.J., et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 114 (2006) 135-142
8. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 44 (2004) e1-e211
9. Kay R., Estioko M., and Wiener I. Primary sick sinus syndrome as an indication for chronic pacemaker therapy in young adults: incidence, clinical features, and long-term evaluation. Am Heart J 103 (1982) 338-342
10. Kusumoto F.M., and Goldschlager N. Cardiac pacing. N Engl J Med 334 (1996) 89-97
11. Rasmussen K. Chronic sinus node disease: natural course and indications for pacing. Eur Heart J 2 (1981) 455-459
12. Linde-Edelstam C., Nordlander R., Pehrsson S.K., and Ryden L. A double-blind study of submaximal exercise tolerance and variation in paced rate in atrial synchronous compared to activity sensor modulated ventricular pacing. Pacing Clin Electrophysiol 15 (1992) 905-915
13. Gammage M., Schofield S., Rankin I., Bennett M., Coles P., and Pentecost B. Benefit of single setting rate responsive ventricular pacing compared with fixed rate demand pacing in elderly patients. Pacing Clin Electrophysiol 14 (1991) 174-180
14. Shaw D.B., Holman R.R., and Gowers J.I. Survival in sinoatrial disorder (sick-sinus syndrome). Br Med J 280 (1980) 139-141
15. Dreifus L.S., Michelson E.L., and Kaplinsky E. Bradyarrhythmias: clinical significance and management. J Am Coll Cardiol 1 (1983) 327-338
16. Rubenstein J.J., Schulman C.L., Yurchak P.M., and DeSanctis R.W. Clinical spectrum of the sick sinus syndrome. Circulation 46 (1972) 5-13
17. Fisher J.D. Role of electrophysiologic testing in the diagnosis and treatment of patients with known and suspected bradycardias and tachycardias. Prog Cardiovasc Dis 24 (1981) 25-90
18. Reiffel J.A., and Kuehnert M.J. Electrophysiological testing of sinus node function: diagnostic and prognostic application-including updated information from sinus node electrograms. Pacing Clin Electrophysiol 17 (1994) 349-365
19. Friedberg C.K., Donoso E., and Stein W.G. Nonsurgical acquired heart block. Ann N Y Acad Sci 111 (1964) 835-847
20. Recommendations for pacemaker prescription for symptomatic bradycardia. Report of a working party of the British Pacing and Electrophysiology Group. Br Heart J 66 (1991) 185-191
21. Kastor J.A. Atrioventricular block (first of two parts). N Engl J Med 292 (1975) 462-465
22. Ector H., Rolies L., and De Geest H. Dynamic electrocardiography and ventricular pauses of 3 seconds and more: etiology and therapeutic implications. Pacing Clin Electrophysiol 6 (1983) 548-551
23. Gallagher J.J., Svenson R.H., Kasell J.H., et al. Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 306 (1982) 194-200
24. Langberg J.J., Chin M.C., Rosenqvist M., et al. Catheter ablation of the atrioventricular junction with radiofrequency energy. Circulation 80 (1989) 1527-1535
25. Glikson M., Dearani J.A., Hyberger L.K., Schaff H.V., Hammill S.C., and Hayes D.L. Indications, effectiveness, and long-term dependency in permanent pacing after cardiac surgery. Am J Cardiol 80 (1997) 1309-1313
26. Kim M.H., Deeb G.M., Eagle K.A., et al. Complete atrioventricular block after valvular heart surgery and the timing of pacemaker implantation. Am J Cardiol 87 (2001) 649-651
27. Koplan B.A., Stevenson W.G., Epstein L.M., Aranki S.F., and Maisel W.H. Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery. J Am Coll Cardiol 41 (2003) 795-801
28. Perloff J.K., Stevenson W.G., Roberts N.K., Cabeen W., and Weiss J. Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. Am J Cardiol 54 (1984) 1074-1081
29. Hiromasa S., Ikeda T., Kubota K., et al. Myotonic dystrophy: ambulatory electrocardiogram, electrophysiologic study, and echocardiographic evaluation. Am Heart J 113 (1987) 1482-1488
30. Stevenson W.G., Perloff J.K., Weiss J.N., and Anderson T.L. Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol 15 (1990) 292-299
31. James T.N., and Fisch C. Observations on the cardiovascular involvement in Freidreich's ataxia. Am Heart J 66 (1963) 164-175
32. Roberts N.K., Perloff J.K., and Kark R.A. Cardiac conduction in the Kearns-Sayre syndrome (a neuromuscular disorder associated with progressive external ophthalmoplegia and pigmentary retinopathy). Report of 2 cases and review of 17 published cases. Am J Cardiol 44 (1979) 1396-1400
33. Charles R., Holt S., Kay J.M., Epstein E.J., and Rees J.R. Myocardial ultrastructure and the development of atrioventricular block in Kearns-Sayre syndrome. Circulation 63 (1981) 214-219
34. James T.N. Observations on the cardiovascular involvement, including the cardiac conduction system, in progressive muscular dystrophy. Am Heart J 63 (1962) 48-56
35. Strasberg B., Amat-Y-Leon F., Dhingra R.C., et al. Natural history of chronic second-degree atrioventricular nodal block. Circulation 63 (1981) 1043-1049
36. Shaw D.B., Kekwick C.A., Veale D., Gowers J., and Whistance T. Survival in second degree atrioventricular block. Br Heart J 53 (1985) 587-593
37. Chokshi S.K., Sarmiento J., Nazari J., Mattioni T., Zheutlin T., and Kehoe R. Exercise-provoked distal atrioventricular block. Am J Cardiol 66 (1990) 114-116
38. Barold S.S., and Mugica J. New Perspectives in Cardiac Pacing (1991), Futura Publishing Co, Mount Kisco, NY 23
39. Gadboys H.L., Wisoff G., and Litwak R.S. Surgical treatment of complete heart block. An analysis of 36 cases. JAMA 189 (1964) 97-102
40. Barold S.S. Indications for permanent cardiac pacing in first-degree AV block: Class I, II, or III?. Pacing Clin Electrophysiol 19 (1996) 747-751
41. Kim Y.H., O'Nunain S., Trouton T., et al. Pseudo-pacemaker syndrome following inadvertent fast pathway ablation for atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 4 (1993) 178-182
42. Zipes D.P. Second-degree atrioventricular block. Circulation 60 (1979) 465-472
43. Zeltser D., Justo D., Halkin A., et al. Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol 44 (2004) 105-108
44. Shohat-Zabarski R., Iakobishvili Z., Kusniec J., Mazur A., and Strasberg B. Paroxysmal atrioventricular block: clinical experience with 20 patients. Int J Cardiol 97 (2004) 399-405
45. Mymin D., Mathewson F.A., Tate R.B., and Manfreda J. The natural history of primary first-degree atrioventricular heart block. N Engl J Med 315 (1986) 1183-1187
46. McAlister H.F., Klementowicz P.T., Andrews C., Fisher J.D., Feld M., and Furman S. Lyme carditis: an important cause of reversible heart block. Ann Intern Med 110 (1989) 339-345
47. Johansson B.W. Complete heart block. A clinical, hemodynamic and pharmacological study in patients with and without an artificial pacemaker. Acta Med Scand Suppl 451 (1966) 1-127
48. Hindman M.C., Wagner G.S., JaRo M., et al. The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion. Circulation 58 (1978) 689-699
49. Donmoyer T.L., DeSanctis R.W., and Austen W.G. Experience with implantable pacemakers using myocardial electrodes in the management of heart block. Ann Thorac Surg 3 (1967) 218-227
50. Edhag O., and Swahn A. Prognosis of patients with complete heart block or arrhythmic syncope who were not treated with artificial pacemakers. A long-term follow-up study of 101 patients. Acta Med Scand 200 (1976) 457-463
51. Levine S.A., Miller H., and Penton G.B. Some clinical features of complete heart block. Circulation 13 (1956) 801-824
52. Dhingra R.C., Denes P., Wu D., Chuquimia R., and Rosen K.M. The significance of second degree atrioventricular block and bundle branch block. Observations regarding site and type of block. Circulation 49 (1974) 638-646
53. Donoso E., Adler L.N., and Friedberg C.K. Unusual forms of second-degree atrioventricular block, including mobitz type-II block, associated with the Morgagni-Adams-Stokes Syndrome. Am Heart J 67 (1964) 150-157
54. Ranganathan N., Dhurandhar R., Phillips J.H., and Wigle E.D. His Bundle electrogram in bundle-branch block. Circulation 45 (1972) 282-294
55. Dhingra R.C., Denes P., Wu D., et al. Syncope in patients with chronic bifascicular block. Significance, causative mechanisms, and clinical implications. Ann Intern Med 81 (1974) 302-306
56. Josephson M. Clinical Cardiac Electrophysiology: Techniques and Interpretations. 2nd edition (1993), Lea & Febiger, Philadelphia, PA 145
57. Kulbertus H., and Collignon P. Association of right bundle-branch block with left superior or inferior intraventricular block. Its relation to complete heart block and Adams-Stokes syndrome. Br Heart J 31 (1969) 435-440
58. DePasquale N.P., and Bruno M.S. Natural history of combined right bundle branch block and left anterior hemiblock (bilateral bundle branch block). Am J Med 54 (1973) 297-303
59. Scheinman M.M., Peters R.W., Modin G., Brennan M., Mies C., and O'Young J. Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Circulation 56 (1977) 240-244
60. Denes P., Dhingra R.C., Wu D., Wyndham C.R., Leon F., and Rosen K.M. Sudden death in patients with chronic bifascicular block. Arch Intern Med 137 (1977) 1005-1010
61. McAnulty J.H., Kauffman S., Murphy E., Kassebaum D.G., and Rahimtoola S.H. Survival in patients with intraventricular conduction defects. Arch Intern Med 138 (1978) 30-35
62. Peters R.W., Scheinman M.M., Modin C., O'Young J., Somelofski C.A., and Mies C. Prophylactic permanent pacemakers for patients with chronic bundle branch block. Am J Med 66 (1979) 978-985
63. Fisch G.R., Zipes D.P., and Fisch C. Bundle branch block and sudden death. Prog Cardiovasc Dis 23 (1980) 187-224
64. McAnulty J.H., Rahimtoola S.H., Murphy E., et al. Natural history of "high-risk" bundle-branch block: final report of a prospective study. N Engl J Med 307 (1982) 137-143
65. Scheinman M.M., Peters R.W., Suave M.J., et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 50 (1982) 1316-1322
66. Morady F., Higgins J., Peters R.W., et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol 54 (1984) 587-591
67. Click R.L., Gersh B.J., Sugrue D.D., et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol 59 (1987) 817-823
68. Ezri M., Lerman B.B., Marchlinski F.E., Buxton A.E., and Josephson M.E. Electrophysiologic evaluation of syncope in patients with bifascicular block. Am Heart J 106 (1983) 693-697
69. Twidale N., Heddle W.F., Ayres B.F., and Tonkin A.M. Clinical implications of electrophysiology study findings in patients with chronic bifascicular block and syncope. Aust N Z J Med 18 (1988) 841-847
70. Englund A., Bergfeldt L., Rehnqvist N., Astrom H., and Rosenqvist M. Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope. J Am Coll Cardiol 26 (1995) 1508-1515
71. Probst P., Pachinger O., Akbar M.A., Leisch F., and Kaindl F. The HQ time in congestive cardiomyopathies. Am Heart J 97 (1979) 436-441
72. Dhingra R.C., Wyndham C., Bauernfeind R., et al. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation 60 (1979) 1455-1464
73. Cheng T.O. Atrial pacing: its diagnostic and therapeutic applications. Prog Cardiovasc Dis 14 (1971) 230-247
74. Brignole M., Menozzi C., Moya A., et al. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 104 (2001) 2045-2050
75. Col J.J., and Weinberg S.L. The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol 29 (1972) 344-350
76. Ritter W.S., Atkins J.M., Blomqvist C.G., and Mullins C.B. Permanent pacing in patients with transient trifascicular block during acute myocardial infarction. Am J Cardiol 38 (1976) 205-208
77. Ginks W.R., Sutton R., Oh W., and Leatham A. Long-term prognosis after acute anterior infarction with atrioventricular block. Br Heart J 39 (1977) 186-189
78. Domenighetti G., and Perret C. Intraventricular conduction disturbances in acute myocardial infarction: short- and long-term prognosis. Eur J Cardiol 11 (1980) 51-59
79. Lamas G.A., Muller J.E., Turi Z.G., et al. A simplified method to predict occurrence of complete heart block during acute myocardial infarction. Am J Cardiol 57 (1986) 1213-1219
80. Brignole M., Menozzi C., Lolli G., Bottoni N., and Gaggioli G. Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome. Am J Cardiol 69 (1992) 1039-1043
81. Brignole M., Menozzi C., Gianfranchi L., Oddone D., Lolli G., and Bertulla A. Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol 68 (1991) 1032-1036
82. Connolly S.J., Sheldon R., Thorpe K.E., et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 289 (2003) 2224-2229
83. Sutton R., Brignole M., Menozzi C., et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 102 (2000) 294-299
84. Ammirati F., Colivicchi F., and Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 104 (2001) 52-57
85. Sheldon R., Koshman M.L., Wilson W., Kieser T., and Rose S. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 81 (1998) 158-162
86. Peters R.W., Scheinman M.M., Morady F., and Jacobson L. Long-term management of recurrent paroxysmal tachycardia by cardiac burst pacing. Pacing Clin Electrophysiol 8 (1985) 35-44
87. Fisher J.D., Johnston D.R., Furman S., Mercando A.D., and Kim S.G. Long-term efficacy of antitachycardia pacing for supraventricular and ventricular tachycardias. Am J Cardiol 60 (1987) 1311-1316
88. Den D.K., Bertholet M., Brugada P., et al. Clinical experience with implantable devices for control of tachyarrhythmias. Pacing Clin Electrophysiol 7 (1984) 548-556
89. Saksena S., Pantopoulos D., Parsonnet V., Rothbart S.T., Hussain S.M., and Gielchinsky I. Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardia. Am J Cardiol 58 (1986) 70-74
90. Barold S.S., Wyndham C.R., Kappenberger L.L., Abinader E.G., Griffin J.C., and Falkoff M.D. Implanted atrial pacemakers for paroxysmal atrial flutter. Long-term efficacy. Ann Intern Med 107 (1987) 144-149
91. Eldar M., Griffin J.C., Abbott J.A., et al. Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 10 (1987) 600-607
92. Eldar M., Griffin J.C., Van Hare G.F., et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 20 (1992) 830-837
93. Saksena S., Prakash A., Hill M., et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 28 (1996) 687-694
94. Saksena S., Delfaut P., Prakash A., Kaushik R.R., and Krol R.B. Multisite electrode pacing for prevention of atrial fibrillation. J Cardiovasc Electrophysiol 9 (1998) S155-S162
95. Lamas G.A., Lee K., Sweeney M., et al. The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J 140 (2000) 541-551
96. Deleted in proof.
97. Fisher J.D., Teichman S.L., Ferrick A., Kim S.G., Waspe L.E., and Martinez M.R. Antiarrhythmic effects of VVI pacing at physiologic rates: a crossover controlled evaluation. Pacing Clin Electrophysiol 10 (1987) 822-830
98. Moss A.J., and Robinson J. Clinical features of the idiopathic long QT syndrome. Circulation 85 (1992) I140-I144
99. Viskin S., Alla S.R., Barron H.V., et al. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 28 (1996) 1262-1268
100. Knight B.P., Gersh B.J., Carlson M.D., et al. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 111 (2005) 240-243
101. Hunt S.A. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) e1-e82
102. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
103. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
104. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
105. Cazeau S., Leclercq C., Lavergne T., et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
106. Fananapazir L., Epstein N.D., Curiel R.V., Panza J.A., Tripodi D., and McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90 (1994) 2731-2742
107. Nishimura R.A., Hayes D.L., Ilstrup D.M., Holmes Jr. D.R., and Tajik A.J. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol 27 (1996) 421-430
108. Nishimura R.A., Symanski J.D., Hurrell D.G., Trusty J.M., Hayes D.L., and Tajik A.J. Dual-chamber pacing for cardiomyopathies: a 1996 clinical perspective. Mayo Clin Proc 71 (1996) 1077-1087
109. Kappenberger L., Linde C., Daubert C., et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J 18 (1997) 1249-1256
110. Nishimura R.A., Trusty J.M., Hayes D.L., et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 29 (1997) 435-441
111. Maron B.J., Nishimura R.A., McKenna W.J., Rakowski H., Josephson M.E., and Kieval R.S. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 99 (1999) 2927-2933
112. Kelly A.M., Porter C.J., McGoon M.D., Espinosa R.E., Osborn M.J., and Hayes D.L. Breath-holding spells associated with significant bradycardia: successful treatment with permanent pacemaker implantation. Pediatrics 108 (2001) 698-702
113. Beder S.D., Gillette P.C., Garson Jr. A., Porter C.B., and McNamara D.G. Symptomatic sick sinus syndrome in children and adolescents as the only manifestation of cardiac abnormality or associated with unoperated congenital heart disease. Am J Cardiol 51 (1983) 1133-1136
114. Lillehei C.W., Sellers R.D., Bonnabeau R.C., and Eliot R.S. Chronic postsurgical complete heart block with particular reference to prognosis, management, and a new P-wave pacemaker. J Thorac Cardiovasc Surg 46 (1963) 436-456
115. Deleted in proof.
116. Michaelsson M., Jonzon A., and Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 92 (1995) 442-449
117. Moak J.P., Barron K.S., Hougen T.J., et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 37 (2001) 238-242
118. Villain E., Coastedoat-Chalumeau N., Marijon E., Boudjemline Y., Piette J.C., and Bonnet D. Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status. J Am Coll Cardiol 48 (2006) 1682-1687
119. Jaeggi E.T., Hamilton R.M., Silverman E.D., Zamora S.A., and Hornberger L.K. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J Am Coll Cardiol 39 (2002) 130-137
120. Pinsky W.W., Gillette P.C., Garson Jr. A., and McNamara D.G. Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block. Pediatrics 69 (1982) 728-733
121. Silka M.J., Manwill J.R., Kron J., and McAnulty J.H. Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates. Am J Cardiol 65 (1990) 488-493
122. Stephenson E.A., Casavant D., Tuzi J., et al. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 92 (2003) 871-876
123. Pfammatter J.P., Paul T., Lehmann C., and Kallfelz H.C. Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 26 (1995) 1002-1007
124. Dewey R.C., Capeless M.A., and Levy A.M. Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block. N Engl J Med 316 (1987) 835-839
125. Sholler G.F., and Walsh E.P. Congenital complete heart block in patients without anatomic cardiac defects. Am Heart J 118 (1989) 1193-1198
126. Cohen M.I., Rhodes L.A., Wernovsky G., Gaynor J.W., Spray T.L., and Rychik J. Atrial pacing: an alternative treatment for protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 121 (2001) 582-583
127. Villain E., Ouarda F., Beyler C., Sidi D., and Abid F. [Predictive factors for late complete atrio-ventricular block after surgical treatment for congenital cardiopathy]. Arch Mal Coeur Vaiss 96 (2003) 495-498
128. Gross G.J., Chiu C.C., Hamilton R.M., Kirsh J.A., and Stephenson E.A. Natural history of postoperative heart block in congenital heart disease: implications for pacing intervention. Heart Rhythm 3 (2006) 601-604
129. Banks M.A., Jenson J., and Kugler J.D. Late development of atrioventricular block after congenital heart surgery in down syndrome. Am J Cardiol 88 (2001) 86-89
130. Krongrad E. Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects. Circulation 57 (1978) 867-870
131. Weindling S.N., Saul J.P., Gamble W.J., Mayer J.E., Wessel D., and Walsh E.P. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol 82 (1998) 525-527
132. Levy W.C., Mozaffarian D., Linker D.T., et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113 (2006) 1424-1433
133. Mozaffarian D., Anker S.D., Anand I., et al. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation 116 (2007) 392-398
134. The Seattle Heart Failure Model. http://www.seattleheartfailuremodel.org Accessed January 2008
135. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (1999) 1882-1890
136. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
137. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
138. Wever E.F., Hauer R.N., van Capelle F.L., et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 91 (1995) 2195-2203
139. Siebels J., and Kuck K.H. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 127 (1994) 1139-1144
140. Connolly S.J., Gent M., Roberts R.S., et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
141. Kuck K.H., Cappato R., Siebels J., and Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (2000) 748-754
142. Connolly S.J., Hallstrom A.P., Cappato R., et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21 (2000) 2071-2078
143. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
144. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
145. Desai A.S., Fang J.C., Maisel W.H., and Baughman K.L. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 292 (2004) 2874-2879
146. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
147. Zareba W., Moss A.J., Daubert J.P., Hall W.J., Robinson J.L., and Andrews M. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 14 (2003) 337-341
148. Viskin S. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 14 (2003) 1130-1131
149. Goel A.K., Berger S., Pelech A., and Dhala A. Implantable cardioverter defibrillator therapy in children with long QT syndrome. Pediatr Cardiol 25 (2004) 370-378
150. Monnig G., Kobe J., Loher A., et al. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up. Heart Rhythm 2 (2005) 497-504
151. Goldenberg I., Mathew J., Moss A.J., et al. Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 48 (2006) 1047-1052
152. Hobbs J.B., Peterson D.R., Moss A.J., et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 296 (2006) 1249-1254
153. Silka M.J., Kron J., Dunnigan A., and Dick M. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation 87 (1993) 800-807
154. Hamilton R.M., Dorian P., Gow R.M., and Williams W.G. Five-year experience with implantable defibrillators in children. Am J Cardiol 77 (1996) 524-526
155. Alexander M.E., Cecchin F., Walsh E.P., Triedman J.K., Bevilacqua L.M., and Berul C.I. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 15 (2004) 72-76
156. Choi G.R., Porter C.B., and Ackerman M.J. Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy. Pediatr Clin North Am 51 (2004) 1289-1303
157. Karamlou T., Silber I., Lao R., et al. Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery. Ann Thorac Surg 81 (2006) 1786-1793
158. Khairy P., Landzberg M.J., Gatzoulis M.A., et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation 109 (2004) 1994-2000
159. Kammeraad J.A., van Deurzen C.H., Sreeram N., et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol 44 (2004) 1095-1102
160. Dubin A.M., Berul C.I., Bevilacqua L.M., et al. The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation. J Card Fail 9 (2003) 375-379